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  Interleukin-17 (IL-17) exerts pleiotropic effects and is important in the pathogenesis of several 
diseases. This cytokine protects animals against several infectious diseases; however, it is also 
involved in the development and progression of autoimmune diseases such as multiple sclerosis, 
rheumatoid arthritis, psoriasis, and inflammatory bowel disease. IL-17 is mainly produced by T 
lymphocytes, and its production is regulated by IL-23.  
    IL-17 induces granulocyte colony-stimulating factor (G-CSF), which is involved in 
granulopoiesis. Granulocytes play critical roles in the development of several inflammatory diseases. 
Because granulocytes have a short lifespan, continuous replacement and robust mechanisms to strictly 
regulate their numbers in the circulating blood are essential. IL-17-producing T lymphocytes play an 
important role in granulocyte homeostasis, and IL-17 overproduction by these cells causes 
granulocytosis. Granulocytosis is a common feature of several autoimmune diseases such as 
rheumatoid arthritis. 
    Recently, it was reported that the hematopoietic loss of a phospholipase C (PLC) isozyme, 
PLCβ3, resulted in a remarkable increase in the number of granulocytes. PLC hydrolyzes 
phosphatidylinositol 4,5-bisphosphate to generate the second messengers inositol 1,4,5-trisphosphate 
and diacylglycerol (DAG), leading to an elevation in the concentration of intracellular calcium ions 
and activation of protein kinase C (PKC). A total of 13 PLC genes have been identified in mammals, 
among which, a PLC isozyme, PLCδ1, is abundantly expressed in the epidermis, the outermost layer 
of the skin. Keratinocytes are the major component of the epidermis. The epidermis has a stratified 
structure maintained by a polarized pattern of keratinocyte growth and differentiation. Keratinocytes 
not only act as a physical barrier to the external environment but also exert important immune 
functions by secreting a variety of cytokines that initiate inflammatory responses. Indeed, 
keratinocytes play critical roles in the development and progression of human inflammatory skin 
diseases such as psoriasis and atopic dermatitis. In this study, I discovered that mice lacking PLCδ1 
showed spontaneous granulocytosis. Unexpectedly, granulocytosis was not caused by the loss of 
PLCδ1 in the hematopoietic compartment, but by the loss of PLCδ1 in the epidermal keratinocytes. 
Furthermore, epidermal ablation of PLCδ1 also resulted in local and/or systemic overproduction of 
IL-23, IL-17, and G-CSF, indicating that PLCδ1 in keratinocytes regulates the activation of the 
IL-23/IL-17 axis and granulocyte homeostasis. 
 
Results 
1. PLCδ1－/－ mice show granulocytosis in a non-hematopoietic-cell intrinsic manner 
  I found that mice lacking PLCδ1 (PLCδ1－/－ mice) had twice the number of peripheral blood 
leukocytes than wild-type mice. Fluorescence-activated cell sorting (FACS) analysis revealed that the 
populations of CD11b+ Gr-1+ granulocytes were markedly increased in the peripheral blood 
leukocytes, spleen, and bone marrow of PLCδ1－/－ mice. In addition, PLCδ1－/－ mice had enlarged 
inguinal lymph nodes (ILNs) and spleens as compared to PLCδ1+/－  mice. Surprisingly, mice 
transplanted with PLCδ1－/－ bone marrow cells had normal numbers of granulocytes and did not 
develop lymphadenopathy and splenomegaly. Thus, granulocytosis in PLCδ1－/－ mice was not due to 
the loss of PLCδ1 in the hematopoietic system. 
2. PLCδ1－/－ mice show local and systemic IL-17 upregulation 
  Because IL-17 has been shown to be a critical cytokine for granulopoiesis, I examined whether the 
IL-17 levels were increased in PLCδ1－/－ mice. In analysis, the serum IL-17 concentration was found 
to be elevated in PLCδ1－/－ mice. In addition, the skin-draining LNs and skin of PLCδ1－/－ mice 
showed IL-17 upregulation, suggesting that the skin plays a pivotal role in IL-17 overproduction in 
PLCδ1－/－ mice. 
3. Epidermal PLCδ1 is sufficient for normal IL-17 levels 
  PLCδ1－/－ mice carrying Foxn1::PLCδ1 (Tg/KO mice) were generated by reintroducing the PLCδ1 
gene into keratinocytes of PLCδ1－/－ mice. Interestingly, the skin of Tg/KO mice showed normal IL-17 
expression. In addition, Tg/KO mice did not exhibit either serum IL-17 elevation or granulocytosis. 
These observations indicate that PLCδ1 expression in keratinocytes was sufficient for the maintenance 
of normal IL-17 levels and granulocyte counts as well as support our interpretation that the loss of 
PLCδ1 in keratinocytes leads to IL-17 upregulation and granulocytosis. 
4. Epidermal PLCδ1 regulates the local and systemic IL-17 levels 
  Keratinocyte-specific conditional PLCδ1-knockout (cKO) mice were created to examine whether 
loss of PLCδ1, specifically in keratinocytes, is sufficient for IL-17 upregulation and granulocytosis. 
Real-time RT-PCR detected IL-17 expression in the cKO skin, but not in the control skin. IL-17 
upregulation was more evident in the epidermis than in the whole skin of cKO mice. IL-17 elevation 
was also observed in the skin-draining LNs and serum of cKO mice. In addition, cKO mice exhibited 
granulocytosis, consistent with local and serum IL-17 upregulation. These results indicate that the loss 
of PLCδ1 in keratinocytes is sufficient to cause IL-17 upregulation and granulocytosis. 
5. Epidermal PLCδ1 regulates IL-23 expression in the skin 
  IL-23 is an IL-17-inducing cytokine. Therefore, I examined IL-23p19 expression and found that its 
mRNA was upregulated in the skin of cKO mice. Interestingly, IL-17 and its key upstream regulator, 
IL-23, were upregulated in the epidermis of cKO mice. IL-23 neutralization with anti-IL-23p19 
antibody decreased the IL-17 mRNA levels in the cKO epidermal sheet, indicating that IL-23 plays a 
critical role in IL-17 upregulation in the epidermis of cKO mice.  
6. Activation of PLC downstream effectors ameliorates IL-23 overproduction 
 I then investigated the mechanisms for IL-23 upregulation. Loss of PLCδ1 in keratinocytes 
resulted in a more than 90% decrease in the overall PLC activity in the epidermis, indicating that 
PLCδ1 is a dominant PLC isoform in the epidermis. The PKC activity was determined by 
examining the phosphorylation status of PKC substrates. Consistent with the decrease in the PLC 
activity, the amount of phosphorylated PKC substrates was also decreased in the cKO epidermis, 
indicating that the epidermal PLCδ1 is required for PKC activity in the epidermis. Then, I 
examined whether activation of PLC downstream signals restores normal IL-23p19 expression. 
Therefore, I treated epidermal sheets from control and cKO mice with ionomycin, a calcium 
ionophore, and phorbol 12-myristate 13-acetate (PMA), a synthetic analogue of DAG and a PKC 
activator, to mimic PLC activation. Treatment with ionomycin and PMA did not alter IL-23p19 
expression in the control epidermal sheet, but decreased it in the cKO epidermal sheet. These results 
suggest that impaired activation of PLC downstream signals contributes to IL-23 upregulation in 
the cKO epidermis. 
7. Keratinocyte-specific PLCδ1－/－ mice show features of human psoriasis 
  As IL-23 and IL-17 are upregulated in the skin of patients with psoriasis, PLCδ1 could be involved 
in the development and/or progression of psoriasis. Interestingly, PLCδ1 protein is decreased in the 
epidermis of the human psoriatic skin and murine psoriatic skin. In addition, the cKO skin showed 
epidermal hyperplasia and immune cell infiltration similar to the skin of psoriasis patients. Real-time 
RT-PCR showed that psoriasis-related inflammatory genes were also upregulated in the cKO skin. 
Thus, the cKO skin shows some characteristics of human skin diseases such as psoriasis.  
8. PLCδ1 in keratinocytes influences contact hypersensitivity 
  To investigate the physiological or pathological significance of IL-17 elevation in cKO mice, I 
examined hapten-induced contact hypersensitivity (CHS) responses, in which IL-17 plays critical 
roles. Mice were sensitized and challenged with dinitrofluorobenzene (DNFB), and the CHS response 
was determined by measuring the extent of ear swelling. Ear swellings of cKO mice were 2.4-, 2.0-, 
2.1-, and 2.9-fold increased as compared with those of control mice at 24, 48, 72, and 96 h after 
challenge, respectively. cKO mice did not exhibit increased ear swelling when IL-17 was neutralized 




In this study, I demonstrated that keratinocyte dysregulation by PLCδ1 deletion results in aberrant 
activation of the IL-23/IL-17 axis and granulocytosis (figure). These findings suggest the clinical 
potentials of targeting body surface-specific inflammatory pathways for the prevention of 






















Figure  Proposed model of local and systemic phenotypes induced by epidermal loss of PLCδ1.   
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ことを明らかにした。これらのことは皮膚での PLCδ1 の欠損が顆粒球増加や IL-17
産生亢進の原因であると考えられた。 
	 そこで次に表皮特異的に PLCδ1の発現を回復させた PLCδ1KOマウスを用いたと
ころ、IL-17産生量や顆粒球数が正常レベルに回復することが判明した。逆に表皮特
異的 PLCδ1欠損マウス (cKOマウス) を用いると、全身の IL-17の増加や顆粒球増
加が引き起こされた。さらに cKOマウス皮膚では IL-23の発現が増加しており、cKO
















	 学位申請者は、これらの結果を Nat. Commun. 3, 963 (2012) に第一著者として報
告しており、学術的成果は充分である。従って本申請論文は博士学位論文に値すると
判断する。 
